Method of administering high-dose, oral magnesium for treatment of chronic pain syndromes or erythromelalgia

Abstract

A method of treating patients, particularly for pain and/or symptoms of erythromelalgia, and other neurovascular or neuropathic disorders, etc. involves administering high doses of magnesium. The magnesium is introduced through several daily administrations, totaling approximately 2-12 times the RDA for magnesium. These higher levels are achieved through increasing daily dosage amounts gradually in response to patient tolerance and until beneficial results are seen. Total magnesium intake is divided over several doses per day and taken with copious amounts of water.

1 . A method of treating a patient comprising the steps of. administering to a patient approximately 2-12 times the daily RDA of magnesium, divided over several daily administrations and/or in extended release form.  
     
     
         2 . The method according to  claim 1  wherein said magnesium is available from the group consisting of magnesium oxide, magnesium chloride, magnesium sulfate, and magnesium protein product.  
     
     
         3 . A method for reducing the pain associated with EM, CRPSI, CIPD, or other chronic disorders comprising orally administering to a patient at least I gram of a magnesium compound per day.  
     
     
         4 . The method of  claim 3  wherein the magnesium compound is selected from the group. consisting of magnesium sulfate, magnesium oxide, magnesium chloride, and magnesium carbonate.  
     
     
         5 . The method of  claim 3  wherein the magnesium compound is in a solid form or a solution.  
     
     
         6 . The method of  claim 5  wherein at least 2.5 grams of magnesium compound is administered per day.  
     
     
         7 . The method of  claim 5  wherein at least 3 grams of magnesium compound is administered per day.  
     
     
         8 . The method of  claim 5  wherein the solid form is an extended release form.  
     
     
         9 . The method of  claim 5  wherein the solid form is a pill.  
     
     
         10 . The method of  claim 5  wherein the solid form is very finely divided magnesium.  
     
     
         11 . The method of  claim 10  when the very finely divided magnesium is in a suspension or dispersion.